| IDO1 in cancer: a Gemini of immune checkpoints L Zhai, E Ladomersky, A Lenzen, B Nguyen, R Patel, KL Lauing, M Wu, ... Cellular & molecular immunology 15 (5), 447-457, 2018 | 373 | 2018 |
| Copper tolerance and virulence in bacteria E Ladomersky, MJ Petris Metallomics 7 (6), 957-964, 2015 | 303 | 2015 |
| IDO1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma E Ladomersky, L Zhai, A Lenzen, KL Lauing, J Qian, DM Scholtens, ... Clinical cancer research 24 (11), 2559-2573, 2018 | 184 | 2018 |
| Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, JA Sosman, B Zhang, ... Frontiers in immunology 11, 1185, 2020 | 177 | 2020 |
| ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis V Shanbhag, K Jasmer-McDonald, S Zhu, AL Martin, N Gudekar, A Khan, ... Proceedings of the National Academy of Sciences 116 (14), 6836-6841, 2019 | 174 | 2019 |
| Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival L Zhai, E Ladomersky, KL Lauing, M Wu, M Genet, G Gritsina, B Győrffy, ... Clinical Cancer Research 23 (21), 6650-6660, 2017 | 166 | 2017 |
| Newly diagnosed glioblastoma: a review on clinical management RV Lukas, DA Wainwright, E Ladomersky, S Sachdev, AM Sonabend, ... Oncology (Williston Park, NY) 33 (3), 91, 2019 | 155 | 2019 |
| The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma E Ladomersky, DM Scholtens, M Kocherginsky, EA Hibler, ET Bartom, ... Frontiers in pharmacology 10, 200, 2019 | 138 | 2019 |
| Advanced age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma E Ladomersky, L Zhai, KL Lauing, A Bell, J Xu, M Kocherginsky, B Zhang, ... Clinical Cancer Research 26 (19), 5232-5245, 2020 | 88 | 2020 |
| Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, B Nguyen, M Genet, ... Clinical cancer research 27 (23), 6514-6528, 2021 | 84 | 2021 |
| Glioblastoma as an age-related neurological disorder in adults M Kim, E Ladomersky, A Mozny, M Kocherginsky, K O’Shea, ZZ Reinstein, ... Neuro-oncology advances 3 (1), vdab125, 2021 | 78 | 2021 |
| Host and pathogen copper-transporting P-type ATPases function antagonistically during Salmonella infection E Ladomersky, A Khan, V Shanbhag, JS Cavet, J Chan, GA Weisman, ... Infection and immunity 85 (9), 10.1128/iai. 00351-17, 2017 | 69 | 2017 |
| Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma L Zhai, E Ladomersky, CR Dostal, KL Lauing, K Swoap, LK Billingham, ... Brain, behavior, and immunity 62, 24-29, 2017 | 57 | 2017 |
| The interplay among psychological distress, the immune system, and brain tumor patient outcomes S Otto-Meyer, J Lumibao, E Kim, E Ladomersky, L Zhai, KL Lauing, ... Current opinion in behavioral sciences 28, 44-50, 2019 | 36 | 2019 |
| Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry TT Nguyen, DH Shin, S Sohoni, SK Singh, Y Rivera-Molina, H Jiang, ... Journal for immunotherapy of cancer 10 (7), 2022 | 35 | 2022 |
| A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors S Otto-Meyer, R DeFaccio, C Dussold, E Ladomersky, L Zhai, KL Lauing, ... Brain, Behavior, & Immunity-Health 2, 100025, 2020 | 35 | 2020 |
| Advanced age negatively impacts survival in an experimental brain tumor model E Ladomersky, L Zhai, G Gritsina, M Genet, KL Lauing, M Wu, CD James, ... Neuroscience letters 630, 203-208, 2016 | 30 | 2016 |
| Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma DC Binder, E Ladomersky, A Lenzen, L Zhai, KL Lauing, SD Otto-Meyer, ... Translational cancer research 7 (Suppl 4), S510, 2018 | 29 | 2018 |
| Identification and characterization of a novel indoleamine 2, 3-dioxygenase 1 protein degrader for glioblastoma LR Bollu, PV Bommi, PJ Monsen, L Zhai, KL Lauing, A Bell, M Kim, ... Journal of Medicinal Chemistry 65 (23), 15642-15662, 2022 | 22 | 2022 |
| Autonomous requirements of the Menkes disease protein in the nervous system VL Hodgkinson, S Zhu, Y Wang, E Ladomersky, K Nickelson, ... American Journal of Physiology-Cell Physiology 309 (10), C660-C668, 2015 | 21 | 2015 |
